Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cogent Biosciences (COGT) Other Operating Expenses (2020)

Cogent Biosciences' Other Operating Expenses history spans 1 years, with the latest figure at $46.9 million for Q3 2020.

  • Quarterly Other Operating Expenses changed N/A to $46.9 million in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $46.9 million through Jun 2021, changed N/A year-over-year, with the annual reading at $46.9 million for FY2020, N/A changed from the prior year.
  • Other Operating Expenses came in at $46.9 million for Q3 2020.
  • In the past five years, Other Operating Expenses ranged from a high of $46.9 million in Q3 2020 to a low of $46.9 million in Q3 2020.